deoxyglucose has been researched along with Gastrointestinal Stromal Tumors in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bauer, S; Fletcher, JA; Grunewald, S; Mühlenberg, T; Podleska, L; Schuler, M; Treckmann, J | 1 |
Banerjee, P; Kung, AL; Tseng, JC; Wang, Y | 1 |
2 other study(ies) available for deoxyglucose and Gastrointestinal Stromal Tumors
Article | Year |
---|---|
Inhibition of KIT-glycosylation by 2-deoxyglucose abrogates KIT-signaling and combination with ABT-263 synergistically induces apoptosis in gastrointestinal stromal tumor.
Topics: Aniline Compounds; Animals; Apoptosis; Cell Line, Tumor; Deoxyglucose; Drug Synergism; Gastrointestinal Stromal Tumors; Glycosylation; Humans; Mice; Mice, Nude; Proto-Oncogene Proteins c-kit; Signal Transduction; Sulfonamides | 2015 |
Incongruity of imaging using fluorescent 2-DG conjugates compared to 18F-FDG in preclinical cancer models.
Topics: Animals; Deoxyglucose; Fluorescence; Fluorodeoxyglucose F18; Gastrointestinal Neoplasms; Gastrointestinal Stromal Tumors; Humans; Imaging, Three-Dimensional; Luminescent Measurements; Mice; Mice, Nude; Microscopy, Confocal; Pyrimidines; Radionuclide Imaging; Spectroscopy, Near-Infrared; Xenograft Model Antitumor Assays | 2012 |